Lynx1 Capital Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-37,436
| Closed | -$621K | – | 24 |
|
|
2024
Q3 | $621K | Sell |
37,436
-6,063
| -14% | -$101K | 0.22% | 12 |
|
|
2024
Q2 | $427K | Sell |
43,499
-66,241
| -60% | -$650K | 0.15% | 13 |
|
|
2024
Q1 | $1.61M | Sell |
109,740
-12,458
| -10% | -$183K | 0.41% | 14 |
|
|
2023
Q4 | $1.78M | Hold |
122,198
| – | – | 0.7% | 12 |
|
|
2023
Q3 | $2.91M | Hold |
122,198
| – | – | 1.93% | 9 |
|
|
2023
Q2 | $1.62M | Buy |
122,198
+33,852
| +38% | +$448K | 1.06% | 11 |
|
|
2023
Q1 | $6.9M | Buy |
88,346
+17,989
| +26% | +$1.4M | 5.75% | 6 |
|
|
2022
Q4 | $5.85M | Buy |
70,357
+26,418
| +60% | +$2.2M | 5.06% | 7 |
|
|
2022
Q3 | $4.04M | Buy |
43,939
+3,647
| +9% | +$335K | 3.65% | 8 |
|
|
2022
Q2 | $6.03M | Buy |
40,292
+26,088
| +184% | +$3.9M | 5.14% | 7 |
|
|
2022
Q1 | $3.44M | Buy |
14,204
+9,413
| +196% | +$2.28M | 3.2% | 10 |
|
|
2021
Q4 | $1.45M | Buy |
+4,791
| New | +$1.45M | 1.26% | 9 |
|